ZYBT
HEALTHCAREZhengye Biotechnology Holding Ltd
Live · NASDAQ · May 9, Close
What's Moving ZYBT Today?
No stock-specific AI insight has been generated for ZYBT yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.99
Fundamentals
Trading
ZYBT News
6 articles- Zhengye Biotechnology Holding Limited Announces Fiscal Year 2025 Financial ResultsYahoo Finance·Apr 28, 2026
- Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share StructureYahoo Finance·Apr 6, 2026
- Zhengye Biotechnology Holding Limited Issues 2026 Chairman’s Letter to ShareholdersYahoo Finance·Feb 10, 2026
- Is Zhengye Biotechnology Holding Limited's (NASDAQ:ZYBT) ROE Of 3.8% Concerning?Yahoo Finance·Sep 14, 2025
- Zhengye Biotechnology Holding Limited Announces Fiscal Year 2024 Financial ResultsYahoo Finance·Jul 3, 2025
- Zhengye Biotechnology Holding Limited Receives NASDAQ Notice Related to Late Filing of Form 20-FYahoo Finance·May 23, 2025
All 6 articles loaded
Price Data
52-Week Range
$0.99
Fundamentals
Trading
About Zhengye Biotechnology Holding Ltd
Zhengye Biotechnology Holding Limited (Ticker: ZYBT) is an innovative biotechnology firm focused on the development and commercialization of advanced biopharmaceutical products. The company leverages its proprietary technologies and a diverse product pipeline to address critical medical needs, positioning itself strategically to enhance treatment outcomes across multiple therapeutic areas. With a robust commitment to research and development, ZYBT aims to drive significant growth and deliver substantial value to its investors, while maintaining a strong emphasis on quality and innovation within the dynamic biotechnology landscape.